The surgical technology provider has formed a strategic investment fund that has co-led a series A round for KēlaHealth.

Human API, a developer of health data management software, secured $20m in a series C round led by Samsung Ventures that included Allianz, Scor, CNO Financial and Guardian Life.

Exact Sciences has shelled out $410m to buy University of Oxford early cancer test company Base Genomics, incorporated in July 2019.

Exact Sciences is set to acquire Johns Hopkins spinout Thrive Earlier Detection for up to $2.15bn in cash and stock, including $1.7bn upfront.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aalto's bone lengthening treatment spinout Synoste has been snapped up after raising funding from investors including Evonik and Mectalent.

Parkwalk made the revelations in a bullish quarterly update that cited the UK government's interest in invigorating deep tech research amid covid-19.

LMU-founded antibody reagent supplier ChromoTek has been picked up after raising funding from Bayern Kapital and HTGF in 2010.

Parent company Legend Holdings contributed 25% of the total as early-stage investment arm Legend Star closed its fourth renminbi-denominated fund.

The small molecule cancer drug developer has launched with series A funding from investors including Partners HealthCare Innovation.